Related Experiment Video
Updated: Mar 13, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
1.3K
Rituximab for Rheumatoid Arthritis.
Marc D Cohen1, Edward Keystone2,3
1Professor Emeritus Mayo Clinic, Rochester, USA. mcohen@rheumdoc.net.
Rheumatology and Therapy
|October 18, 2016
Summary
Rituximab effectively treats rheumatoid arthritis (RA) in various patient groups. While generally safe, careful screening and monitoring are essential for optimal outcomes in RA management.
Area of Science:
- Immunology
- Rheumatology
Background:
- Rheumatoid arthritis (RA) is a chronic autoimmune disease.
- B cells play a key role in RA pathogenesis.
- Existing RA treatments have limitations.
Approach:
- Rituximab, a chimeric monoclonal antibody, targets the CD20 molecule on B cells.
- It depletes B cells, impacting RA disease activity.
- Clinical trials evaluated rituximab efficacy in diverse RA patient populations.
Key Points:
- Rituximab demonstrated efficacy in methotrexate-naïve, methotrexate-intolerant, and TNF inhibitor-intolerant RA patients.
- Optimal dosing, retreatment intervals, and concomitant therapies require further study.
- Efficacy appears higher in seropositive patients and those with limited prior TNF inhibitor exposure.
- Rituximab has a manageable safety profile, with rare serious infections and opportunistic infections. Hepatitis B reactivation and progressive multifocal leukoencephalopathy warrant vigilance.
- Infusion reactions are typically mild and more common with the first dose. Hypogammaglobulinemia risk is under investigation.
Conclusions:
- Rituximab is a valuable therapeutic option for rheumatoid arthritis.
- Pre-treatment screening for infections, cardiac status, and hypersensitivity is crucial.
- Vaccinations prior to rituximab initiation are recommended.
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
693
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
693
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
636
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
636
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
895
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
895
01:21Rheumatic Heart Disease III: Medical Management
451
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
451
01:20Rheumatic Heart Disease IV: Nursing Management
404
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
404
01:23Rheumatic Heart Disease I: Introduction
735
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
735